Sun Y, Yan L-Q, Liang Y, Li X-L, Cao X-J, Lu C
Department of Microbiology, Nanjing Medical University, Nanjing, China.
Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):3-8.
Epidural scar adhesion is one of the major causes of the failed back surgery syndrome after laminectomy. Recent studies have shown that simvastatin has potent anti-fibrotic and anti-inflammatory properties. This study evaluates the effect of the topical application of simvastatin on reducing epidural scar adhesion after laminectomy in rats.
Thirty-six male Sprague-Dawley rats were randomly divided into three groups: control, chitosan and simvastatin group. After laminectomy was performed at L1 level, simvastatin and chitosan were applied to the laminectomy sites. The control group received no additional treatment. Four weeks later, the rats were killed and the epidural adhesion was evaluated by macroscopic assessment, hydroxyproline content analysis and histological analysis. The number of fibroblasts and the optical density of the collagen were also determined.
The results showed that simvastatin could reduce epidural scar adhesion in rats. Little epidural adhesions were seen in the laminectomy sites treated with simvastatin. The hydroxyproline content, the number of fibroblasts and the optical density of the collagen in the simvastatin group were significantly less than those of the chitosan and control group. However, dense epidural adhesion was found in control group.
Topical application of simvastatin could reduce epidural scar adhesion after laminectomy in rats. Further research is necessary to determine the optimal dosage and the safety of simvastatin.
硬膜外瘢痕粘连是椎板切除术后腰椎手术失败综合征的主要原因之一。近期研究表明,辛伐他汀具有强大的抗纤维化和抗炎特性。本研究评估局部应用辛伐他汀对减少大鼠椎板切除术后硬膜外瘢痕粘连的效果。
将36只雄性Sprague-Dawley大鼠随机分为三组:对照组、壳聚糖组和辛伐他汀组。在L1水平进行椎板切除术后,将辛伐他汀和壳聚糖应用于椎板切除部位。对照组不接受额外治疗。四周后,处死大鼠,通过宏观评估、羟脯氨酸含量分析和组织学分析评估硬膜外粘连情况。同时还测定了成纤维细胞数量和胶原蛋白的光密度。
结果表明,辛伐他汀可减少大鼠硬膜外瘢痕粘连。在应用辛伐他汀治疗的椎板切除部位,几乎未见硬膜外粘连。辛伐他汀组的羟脯氨酸含量、成纤维细胞数量和胶原蛋白光密度均显著低于壳聚糖组和对照组。然而,对照组发现有致密的硬膜外粘连。
局部应用辛伐他汀可减少大鼠椎板切除术后的硬膜外瘢痕粘连。有必要进一步研究以确定辛伐他汀的最佳剂量和安全性。